CLINICAL TRIALS PROFILE FOR MIRENA
✉ Email this page to a colleague
All Clinical Trials for MIRENA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00185380 ↗ | Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS) | Completed | Bayer | Phase 2 | 2005-04-01 | The purpose of this study is to investigate if drug doses lower than the one released from Mirena® would be as effective for contraception as Mirena®. Subjects participating in the study will be randomly assigned to be inserted with any of the three different intrauterine systems (IUSs). The IUSs are nearly alike except that the amount of hormone released from them is different. |
| NCT00360490 ↗ | Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS) | Completed | Bayer | Phase 3 | 2006-07-01 | The purpose of this study is to determine whether the levonorgestrel-releasing intrauterine system is effective in decreasing menstrual blood loss. |
| NCT00393198 ↗ | Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia | Completed | Bayer | Phase 4 | 2006-10-01 | The purpose of this study is to assess the bleeding pattern during the last 3 months of the first MIRENA® and the first year of the second MIRENA® use. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MIRENA
Condition Name
Clinical Trial Locations for MIRENA
Trials by Country
Clinical Trial Progress for MIRENA
Clinical Trial Phase
Clinical Trial Sponsors for MIRENA
Sponsor Name
